

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.69516820 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.61848933 |
| 3 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.32157256 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.29447390 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.29447390 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.24202774 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.78903160 |
| 8 | negative regulation of cell killing (GO:0031342) | 4.78903160 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.63653763 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 4.63653763 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 4.63653763 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 4.63653763 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.63653763 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.63653763 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.54997289 |
| 16 | detection of other organism (GO:0098543) | 4.48141219 |
| 17 | detection of bacterium (GO:0016045) | 4.35183013 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 4.17028189 |
| 19 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.15738405 |
| 20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.13458805 |
| 21 | leukocyte aggregation (GO:0070486) | 4.13451531 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 4.10664474 |
| 23 | positive regulation of B cell differentiation (GO:0045579) | 4.05096594 |
| 24 | regulation of B cell differentiation (GO:0045577) | 4.03379750 |
| 25 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.98427753 |
| 26 | regulation of gamma-delta T cell activation (GO:0046643) | 3.94176476 |
| 27 | T cell migration (GO:0072678) | 3.92410062 |
| 28 | B cell receptor signaling pathway (GO:0050853) | 3.86534901 |
| 29 | negative thymic T cell selection (GO:0045060) | 3.85226248 |
| 30 | negative T cell selection (GO:0043383) | 3.84394007 |
| 31 | detection of external biotic stimulus (GO:0098581) | 3.75875036 |
| 32 | respiratory burst (GO:0045730) | 3.74781752 |
| 33 | tolerance induction (GO:0002507) | 3.71129350 |
| 34 | positive regulation of antigen processing and presentation (GO:0002579) | 3.70060673 |
| 35 | cellular extravasation (GO:0045123) | 3.69972355 |
| 36 | positive thymic T cell selection (GO:0045059) | 3.68194179 |
| 37 | macrophage activation involved in immune response (GO:0002281) | 3.66254360 |
| 38 | mast cell activation (GO:0045576) | 3.59630874 |
| 39 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.55342016 |
| 40 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.54011329 |
| 41 | positive regulation of interferon-alpha production (GO:0032727) | 3.49863469 |
| 42 | detection of molecule of bacterial origin (GO:0032490) | 3.48050421 |
| 43 | interferon-gamma production (GO:0032609) | 3.47729625 |
| 44 | response to peptidoglycan (GO:0032494) | 3.45066435 |
| 45 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.44557028 |
| 46 | myeloid cell activation involved in immune response (GO:0002275) | 3.42348349 |
| 47 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.42272336 |
| 48 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.39145558 |
| 49 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.38847553 |
| 50 | regulation of interferon-alpha production (GO:0032647) | 3.37548333 |
| 51 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.35980099 |
| 52 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.34513399 |
| 53 | myeloid dendritic cell activation (GO:0001773) | 3.34353451 |
| 54 | detection of biotic stimulus (GO:0009595) | 3.33418530 |
| 55 | negative regulation of phagocytosis (GO:0050765) | 3.32851036 |
| 56 | B cell mediated immunity (GO:0019724) | 3.32355926 |
| 57 | response to interleukin-15 (GO:0070672) | 3.31671648 |
| 58 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.31096675 |
| 59 | neutrophil activation (GO:0042119) | 3.29837894 |
| 60 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.29560212 |
| 61 | leukocyte cell-cell adhesion (GO:0007159) | 3.27963939 |
| 62 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.27340309 |
| 63 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.27246149 |
| 64 | germinal center formation (GO:0002467) | 3.23872045 |
| 65 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.23841246 |
| 66 | negative regulation of interleukin-12 production (GO:0032695) | 3.23100792 |
| 67 | granulocyte activation (GO:0036230) | 3.21034502 |
| 68 | macrophage activation (GO:0042116) | 3.20674907 |
| 69 | regulation of leukocyte degranulation (GO:0043300) | 3.19023893 |
| 70 | regulation of antigen processing and presentation (GO:0002577) | 3.18861301 |
| 71 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.18673140 |
| 72 | negative regulation of T cell mediated immunity (GO:0002710) | 3.17946931 |
| 73 | defense response to protozoan (GO:0042832) | 3.16845158 |
| 74 | response to muramyl dipeptide (GO:0032495) | 3.16807804 |
| 75 | thymic T cell selection (GO:0045061) | 3.15572406 |
| 76 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.13650328 |
| 77 | positive regulation of mast cell degranulation (GO:0043306) | 3.13650328 |
| 78 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.13330842 |
| 79 | response to type I interferon (GO:0034340) | 3.12668174 |
| 80 | type I interferon signaling pathway (GO:0060337) | 3.11279580 |
| 81 | cellular response to type I interferon (GO:0071357) | 3.11279580 |
| 82 | regulation of tolerance induction (GO:0002643) | 3.10206629 |
| 83 | myeloid dendritic cell differentiation (GO:0043011) | 3.07689527 |
| 84 | cellular response to interleukin-15 (GO:0071350) | 3.06721317 |
| 85 | response to protozoan (GO:0001562) | 3.05316293 |
| 86 | cellular response to zinc ion (GO:0071294) | 3.04912350 |
| 87 | negative regulation of granulocyte differentiation (GO:0030853) | 2.99606257 |
| 88 | T-helper 1 type immune response (GO:0042088) | 2.98179883 |
| 89 | T cell selection (GO:0045058) | 2.97646770 |
| 90 | positive T cell selection (GO:0043368) | 2.95942885 |
| 91 | pinocytosis (GO:0006907) | 2.95216550 |
| 92 | regulation of T cell tolerance induction (GO:0002664) | 2.93243815 |
| 93 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.92466091 |
| 94 | leukocyte degranulation (GO:0043299) | 2.92184930 |
| 95 | positive regulation of isotype switching (GO:0045830) | 2.91990289 |
| 96 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.91667785 |
| 97 | response to host immune response (GO:0052572) | 2.91667785 |
| 98 | activated T cell proliferation (GO:0050798) | 2.91218791 |
| 99 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.90170735 |
| 100 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.88852401 |
| 101 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.86667919 |
| 102 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.86667919 |
| 103 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.86663727 |
| 104 | positive regulation of mast cell activation (GO:0033005) | 2.86523278 |
| 105 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.86472782 |
| 106 | cellular response to interferon-beta (GO:0035458) | 2.86343171 |
| 107 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.84937169 |
| 108 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.84401310 |
| 109 | negative regulation of innate immune response (GO:0045824) | 2.83615456 |
| 110 | myeloid leukocyte activation (GO:0002274) | 2.83259936 |
| 111 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.82024722 |
| 112 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.82018208 |
| 113 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.81169030 |
| 114 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.80098520 |
| 115 | response to host (GO:0075136) | 2.80098520 |
| 116 | response to host defenses (GO:0052200) | 2.80098520 |
| 117 | microglial cell activation (GO:0001774) | 2.77879549 |
| 118 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.77252029 |
| 119 | NIK/NF-kappaB signaling (GO:0038061) | 2.75818418 |
| 120 | mature B cell differentiation (GO:0002335) | 2.75275346 |
| 121 | cellular defense response (GO:0006968) | 2.73548776 |
| 122 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.73062281 |
| 123 | T cell proliferation (GO:0042098) | 2.72119521 |
| 124 | regulation of mast cell activation (GO:0033003) | 2.72082454 |
| 125 | positive regulation of interleukin-2 production (GO:0032743) | 2.71825331 |
| 126 | T cell costimulation (GO:0031295) | 2.70220883 |
| 127 | regulation of mast cell degranulation (GO:0043304) | 2.69807055 |
| 128 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.69581784 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.18356045 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.93975081 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.46059742 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.16651801 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.80889370 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.76717073 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.51262599 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.48031440 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.33007499 |
| 10 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.17665050 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.11627602 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.03601466 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.92521323 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.83139619 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.77197926 |
| 16 | * MYC_22102868_ChIP-Seq_BL_Human | 2.76516140 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.73781737 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.71330982 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.62424409 |
| 20 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.61934277 |
| 21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.54064085 |
| 22 | * MYB_26560356_Chip-Seq_TH2_Human | 2.53518526 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.51566687 |
| 24 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.43971307 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.39965397 |
| 26 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.39539367 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 2.38353817 |
| 28 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.23159920 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.19732414 |
| 30 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.16502224 |
| 31 | * MYB_26560356_Chip-Seq_TH1_Human | 2.13471867 |
| 32 | * BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.11403774 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.06317720 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.06299948 |
| 35 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.01998502 |
| 36 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99379277 |
| 37 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.90790701 |
| 38 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.87012173 |
| 39 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86913559 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.85135548 |
| 41 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.79908769 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.75377985 |
| 43 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59141940 |
| 44 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.58659888 |
| 45 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58599205 |
| 46 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.57891544 |
| 47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.57711182 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.54888822 |
| 49 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.52989015 |
| 50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.50059891 |
| 51 | * MAF_26560356_Chip-Seq_TH2_Human | 1.48227632 |
| 52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.47656504 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.44834610 |
| 54 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.44347332 |
| 55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41631910 |
| 56 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39733814 |
| 57 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37921878 |
| 58 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.33790789 |
| 59 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.32179290 |
| 60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.31646610 |
| 61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31065150 |
| 62 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.30475966 |
| 63 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.27278849 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24292070 |
| 65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.22434295 |
| 66 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22194420 |
| 67 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20272250 |
| 68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19489294 |
| 69 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17242879 |
| 70 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17140346 |
| 71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.17026597 |
| 72 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.16247987 |
| 73 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15882232 |
| 74 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.15398318 |
| 75 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.14722916 |
| 76 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.14124911 |
| 77 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.13921232 |
| 78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13372541 |
| 79 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12604772 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11762009 |
| 81 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.11676336 |
| 82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10607016 |
| 83 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.10039220 |
| 84 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06733826 |
| 85 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05525475 |
| 86 | GATA1_22025678_ChIP-Seq_K562_Human | 1.04918314 |
| 87 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04094442 |
| 88 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03406656 |
| 89 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02497028 |
| 90 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02129664 |
| 91 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01851395 |
| 92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01556654 |
| 93 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.00612797 |
| 94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97813981 |
| 95 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97388859 |
| 96 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96510084 |
| 97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96000280 |
| 98 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.92721222 |
| 99 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.88481585 |
| 100 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.87434337 |
| 101 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84145858 |
| 102 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83737505 |
| 103 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83294663 |
| 104 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.82638362 |
| 105 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.80539032 |
| 106 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.79500290 |
| 107 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.79302512 |
| 108 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.75349575 |
| 109 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73480021 |
| 110 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.73474270 |
| 111 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.73002250 |
| 112 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72745630 |
| 113 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.71529398 |
| 114 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.71376523 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.48290253 |
| 2 | MP0005671_abnormal_response_to | 3.47670497 |
| 3 | MP0003436_decreased_susceptibility_to | 3.36261106 |
| 4 | MP0000685_abnormal_immune_system | 3.23478961 |
| 5 | MP0005000_abnormal_immune_tolerance | 3.14526862 |
| 6 | MP0001800_abnormal_humoral_immune | 3.11642406 |
| 7 | MP0005387_immune_system_phenotype | 3.06970829 |
| 8 | MP0001790_abnormal_immune_system | 3.06970829 |
| 9 | MP0006082_CNS_inflammation | 3.05573760 |
| 10 | MP0009785_altered_susceptibility_to | 3.02588390 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.89663201 |
| 12 | MP0002419_abnormal_innate_immunity | 2.87265703 |
| 13 | MP0005025_abnormal_response_to | 2.86917561 |
| 14 | MP0003303_peritoneal_inflammation | 2.83459578 |
| 15 | * MP0002148_abnormal_hypersensitivity_rea | 2.75828627 |
| 16 | * MP0002723_abnormal_immune_serum | 2.73399756 |
| 17 | * MP0002420_abnormal_adaptive_immunity | 2.68593407 |
| 18 | * MP0001819_abnormal_immune_cell | 2.67308103 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.59610998 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.44622695 |
| 21 | MP0005058_abnormal_lysosome_morphology | 2.43344068 |
| 22 | * MP0002398_abnormal_bone_marrow | 2.31656262 |
| 23 | MP0003724_increased_susceptibility_to | 2.31450400 |
| 24 | MP0002405_respiratory_system_inflammati | 2.27109337 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 2.25408882 |
| 26 | MP0002396_abnormal_hematopoietic_system | 2.20410633 |
| 27 | * MP0000716_abnormal_immune_system | 2.19302392 |
| 28 | MP0004510_myositis | 2.08009380 |
| 29 | MP0000689_abnormal_spleen_morphology | 2.04141481 |
| 30 | MP0002166_altered_tumor_susceptibility | 2.03613276 |
| 31 | MP0002722_abnormal_immune_system | 1.94804131 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.91770399 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.90230391 |
| 34 | MP0004947_skin_inflammation | 1.90214794 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.88954294 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.88650237 |
| 37 | MP0001853_heart_inflammation | 1.87674230 |
| 38 | * MP0002429_abnormal_blood_cell | 1.83576739 |
| 39 | MP0001873_stomach_inflammation | 1.78706940 |
| 40 | MP0002006_tumorigenesis | 1.77406980 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.74246996 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.65420843 |
| 43 | MP0005310_abnormal_salivary_gland | 1.61306625 |
| 44 | MP0000703_abnormal_thymus_morphology | 1.54411398 |
| 45 | MP0005451_abnormal_body_composition | 1.52890586 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.52192788 |
| 47 | MP0004808_abnormal_hematopoietic_stem | 1.52182088 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.50470119 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.50470119 |
| 50 | MP0009278_abnormal_bone_marrow | 1.48376403 |
| 51 | MP0008469_abnormal_protein_level | 1.47053543 |
| 52 | MP0002933_joint_inflammation | 1.46391141 |
| 53 | MP0003448_altered_tumor_morphology | 1.40141707 |
| 54 | MP0008260_abnormal_autophagy | 1.37692474 |
| 55 | MP0003866_abnormal_defecation | 1.35909490 |
| 56 | MP0000858_altered_metastatic_potential | 1.35225228 |
| 57 | MP0000490_abnormal_crypts_of | 1.30295993 |
| 58 | MP0005174_abnormal_tail_pigmentation | 1.29470871 |
| 59 | MP0000343_altered_response_to | 1.27849950 |
| 60 | MP0001851_eye_inflammation | 1.27568110 |
| 61 | MP0009840_abnormal_foam_cell | 1.19171864 |
| 62 | MP0003075_altered_response_to | 1.14138202 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.07465785 |
| 64 | MP0003806_abnormal_nucleotide_metabolis | 1.05847138 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.05202280 |
| 66 | MP0004883_abnormal_blood_vessel | 1.03168272 |
| 67 | MP0009764_decreased_sensitivity_to | 1.00671028 |
| 68 | MP0005166_decreased_susceptibility_to | 0.96598024 |
| 69 | MP0010307_abnormal_tumor_latency | 0.95883831 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 0.94794019 |
| 71 | MP0002019_abnormal_tumor_incidence | 0.87583244 |
| 72 | MP0008004_abnormal_stomach_pH | 0.86780322 |
| 73 | MP0009763_increased_sensitivity_to | 0.85768024 |
| 74 | MP0010352_gastrointestinal_tract_polyps | 0.84224361 |
| 75 | MP0005164_abnormal_response_to | 0.83552713 |
| 76 | MP0004381_abnormal_hair_follicle | 0.81133463 |
| 77 | MP0003828_pulmonary_edema | 0.80919764 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 0.78384232 |
| 79 | MP0005075_abnormal_melanosome_morpholog | 0.77303743 |
| 80 | MP0005390_skeleton_phenotype | 0.76341317 |
| 81 | MP0000249_abnormal_blood_vessel | 0.75626844 |
| 82 | MP0002132_abnormal_respiratory_system | 0.74462629 |
| 83 | MP0003566_abnormal_cell_adhesion | 0.72041975 |
| 84 | MP0000604_amyloidosis | 0.71612309 |
| 85 | MP0005076_abnormal_cell_differentiation | 0.69489995 |
| 86 | MP0000015_abnormal_ear_pigmentation | 0.68529871 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.68278657 |
| 88 | MP0005023_abnormal_wound_healing | 0.67906634 |
| 89 | MP0001663_abnormal_digestive_system | 0.67826334 |
| 90 | MP0008057_abnormal_DNA_replication | 0.66562898 |
| 91 | MP0000920_abnormal_myelination | 0.64432998 |
| 92 | MP0003795_abnormal_bone_structure | 0.63798554 |
| 93 | MP0008874_decreased_physiological_sensi | 0.63221215 |
| 94 | MP0002139_abnormal_hepatobiliary_system | 0.62796588 |
| 95 | MP0002136_abnormal_kidney_physiology | 0.62366074 |
| 96 | MP0003690_abnormal_glial_cell | 0.61833888 |
| 97 | MP0008007_abnormal_cellular_replicative | 0.60794234 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 0.60326868 |
| 99 | MP0008873_increased_physiological_sensi | 0.58767885 |
| 100 | MP0003091_abnormal_cell_migration | 0.56991362 |
| 101 | MP0002095_abnormal_skin_pigmentation | 0.56791732 |
| 102 | MP0000371_diluted_coat_color | 0.55769417 |
| 103 | MP0000313_abnormal_cell_death | 0.52734311 |
| 104 | MP0002138_abnormal_hepatobiliary_system | 0.51834570 |
| 105 | MP0000569_abnormal_digit_pigmentation | 0.51746421 |
| 106 | MP0003077_abnormal_cell_cycle | 0.50903654 |
| 107 | MP0002009_preneoplasia | 0.49169732 |
| 108 | MP0003453_abnormal_keratinocyte_physiol | 0.48608197 |
| 109 | MP0000609_abnormal_liver_physiology | 0.48551851 |
| 110 | MP0010094_abnormal_chromosome_stability | 0.48544417 |
| 111 | MP0003045_fibrosis | 0.48104633 |
| 112 | MP0000598_abnormal_liver_morphology | 0.47058744 |
| 113 | MP0005319_abnormal_enzyme/_coenzyme | 0.46770716 |
| 114 | MP0005381_digestive/alimentary_phenotyp | 0.46298372 |
| 115 | MP0002693_abnormal_pancreas_physiology | 0.46128325 |
| 116 | MP0003329_amyloid_beta_deposits | 0.46125752 |
| 117 | MP0004782_abnormal_surfactant_physiolog | 0.44935189 |
| 118 | MP0000477_abnormal_intestine_morphology | 0.43575102 |
| 119 | MP0001915_intracranial_hemorrhage | 0.42976054 |
| 120 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.42481327 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.13695938 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.58228584 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.29284544 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.53167368 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 4.46370124 |
| 6 | Myositis (HP:0100614) | 4.40078234 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.31413712 |
| 8 | Recurrent fungal infections (HP:0002841) | 4.29703409 |
| 9 | Recurrent viral infections (HP:0004429) | 4.03805571 |
| 10 | IgM deficiency (HP:0002850) | 4.02852516 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.86132446 |
| 12 | Chronic otitis media (HP:0000389) | 3.84556011 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 3.78196365 |
| 14 | Recurrent skin infections (HP:0001581) | 3.78061501 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 3.64111927 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 3.63474597 |
| 17 | Obstructive lung disease (HP:0006536) | 3.56014103 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.56014103 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.50891234 |
| 20 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.50891234 |
| 21 | Pustule (HP:0200039) | 3.45663623 |
| 22 | Meningitis (HP:0001287) | 3.44544002 |
| 23 | Cellulitis (HP:0100658) | 3.42551882 |
| 24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.40181434 |
| 25 | Recurrent bronchitis (HP:0002837) | 3.38550285 |
| 26 | Orchitis (HP:0100796) | 3.35431038 |
| 27 | Nasal polyposis (HP:0100582) | 3.34776957 |
| 28 | T lymphocytopenia (HP:0005403) | 3.32306090 |
| 29 | Abnormality of T cell number (HP:0011839) | 3.29335181 |
| 30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.26362136 |
| 31 | Stomatitis (HP:0010280) | 3.25570770 |
| 32 | Gastrointestinal infarctions (HP:0005244) | 3.21194416 |
| 33 | Autoimmune thrombocytopenia (HP:0001973) | 3.18719708 |
| 34 | Dysostosis multiplex (HP:0000943) | 3.17364622 |
| 35 | Panhypogammaglobulinemia (HP:0003139) | 3.16437335 |
| 36 | Abnormality of T cells (HP:0002843) | 3.13609313 |
| 37 | Petechiae (HP:0000967) | 3.13051263 |
| 38 | Vasculitis (HP:0002633) | 3.12403957 |
| 39 | Inflammation of the large intestine (HP:0002037) | 3.11893816 |
| 40 | Optic neuritis (HP:0100653) | 3.08503382 |
| 41 | Retrobulbar optic neuritis (HP:0100654) | 3.08503382 |
| 42 | Spontaneous hematomas (HP:0007420) | 3.05451023 |
| 43 | Abnormality of the nasal mucosa (HP:0000433) | 3.02662048 |
| 44 | Gingivitis (HP:0000230) | 3.01826710 |
| 45 | Gastrointestinal inflammation (HP:0004386) | 3.01795570 |
| 46 | Glomerulonephritis (HP:0000099) | 3.00274068 |
| 47 | Agammaglobulinemia (HP:0004432) | 2.97507321 |
| 48 | Colitis (HP:0002583) | 2.93639152 |
| 49 | Abnormality of glycolipid metabolism (HP:0010969) | 2.90644818 |
| 50 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.90644818 |
| 51 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.90644818 |
| 52 | Thrombocytosis (HP:0001894) | 2.85922349 |
| 53 | Interstitial pulmonary disease (HP:0006530) | 2.83447853 |
| 54 | Leukocytosis (HP:0001974) | 2.82903236 |
| 55 | Abnormality of T cell physiology (HP:0011840) | 2.81692777 |
| 56 | Chest pain (HP:0100749) | 2.79717815 |
| 57 | Prolonged bleeding time (HP:0003010) | 2.71996140 |
| 58 | Lymphopenia (HP:0001888) | 2.71733552 |
| 59 | Keratoconjunctivitis (HP:0001096) | 2.71091393 |
| 60 | Increased IgM level (HP:0003496) | 2.71082029 |
| 61 | Periodontitis (HP:0000704) | 2.67393867 |
| 62 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.65346381 |
| 63 | Thyroiditis (HP:0100646) | 2.62597917 |
| 64 | Eosinophilia (HP:0001880) | 2.58652417 |
| 65 | Pulmonary infiltrates (HP:0002113) | 2.55638489 |
| 66 | Purpura (HP:0000979) | 2.54779663 |
| 67 | Mucopolysacchariduria (HP:0008155) | 2.52405350 |
| 68 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.52405350 |
| 69 | IgG deficiency (HP:0004315) | 2.51917661 |
| 70 | Agnosia (HP:0010524) | 2.50967082 |
| 71 | Epistaxis (HP:0000421) | 2.48533687 |
| 72 | Disinhibition (HP:0000734) | 2.47110526 |
| 73 | Combined immunodeficiency (HP:0005387) | 2.44105539 |
| 74 | Severe combined immunodeficiency (HP:0004430) | 2.43563940 |
| 75 | Sepsis (HP:0100806) | 2.43244103 |
| 76 | Pulmonary embolism (HP:0002204) | 2.42687874 |
| 77 | Abnormality of eosinophils (HP:0001879) | 2.42549480 |
| 78 | Loss of speech (HP:0002371) | 2.42215150 |
| 79 | Arterial thrombosis (HP:0004420) | 2.40352492 |
| 80 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.40190332 |
| 81 | Osteomyelitis (HP:0002754) | 2.38946252 |
| 82 | Gastrointestinal stroma tumor (HP:0100723) | 2.38749418 |
| 83 | Amyloidosis (HP:0011034) | 2.37608105 |
| 84 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.35688660 |
| 85 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.35688660 |
| 86 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.35688660 |
| 87 | Hemoptysis (HP:0002105) | 2.35611074 |
| 88 | Abnormality of B cell number (HP:0010975) | 2.35276672 |
| 89 | B lymphocytopenia (HP:0010976) | 2.35276672 |
| 90 | Granulocytopenia (HP:0001913) | 2.34074137 |
| 91 | Restrictive lung disease (HP:0002091) | 2.33953752 |
| 92 | Increased IgE level (HP:0003212) | 2.33772954 |
| 93 | Recurrent pneumonia (HP:0006532) | 2.33554299 |
| 94 | Encephalitis (HP:0002383) | 2.33553186 |
| 95 | Hematochezia (HP:0002573) | 2.33286988 |
| 96 | Increased serum ferritin (HP:0003281) | 2.33061969 |
| 97 | Chronic diarrhea (HP:0002028) | 2.32596209 |
| 98 | Autoimmune hemolytic anemia (HP:0001890) | 2.28082210 |
| 99 | Hepatosplenomegaly (HP:0001433) | 2.26899382 |
| 100 | Episodic fever (HP:0001954) | 2.23730351 |
| 101 | Abnormality of the prostate (HP:0008775) | 2.22450711 |
| 102 | Abnormality of the pleura (HP:0002103) | 2.21549148 |
| 103 | Recurrent sinusitis (HP:0011108) | 2.20987131 |
| 104 | Recurrent lower respiratory tract infections (HP:0002783) | 2.19540790 |
| 105 | Urticaria (HP:0001025) | 2.18766092 |
| 106 | Hypergammaglobulinemia (HP:0010702) | 2.18097928 |
| 107 | Gingival bleeding (HP:0000225) | 2.17228893 |
| 108 | Gangrene (HP:0100758) | 2.17212839 |
| 109 | Abnormal platelet function (HP:0011869) | 2.17124454 |
| 110 | Impaired platelet aggregation (HP:0003540) | 2.17124454 |
| 111 | Keratoconjunctivitis sicca (HP:0001097) | 2.12770750 |
| 112 | IgA deficiency (HP:0002720) | 2.12117557 |
| 113 | Anorexia (HP:0002039) | 2.10791426 |
| 114 | Verrucae (HP:0200043) | 2.09520474 |
| 115 | Papilloma (HP:0012740) | 2.09520474 |
| 116 | Emphysema (HP:0002097) | 2.08448869 |
| 117 | Polyneuropathy (HP:0001271) | 2.04095000 |
| 118 | Abnormality of iron homeostasis (HP:0011031) | 2.03155187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.28179733 |
| 2 | TXK | 3.42720580 |
| 3 | BLK | 3.25848645 |
| 4 | TYK2 | 2.87516957 |
| 5 | PRPF4B | 2.67660934 |
| 6 | KIT | 2.64147453 |
| 7 | IRAK4 | 2.58913314 |
| 8 | ZAP70 | 2.48055632 |
| 9 | TBK1 | 2.45180268 |
| 10 | JAK3 | 2.40522096 |
| 11 | MAP3K14 | 2.30338893 |
| 12 | TGFBR2 | 2.29876579 |
| 13 | STK10 | 2.24596090 |
| 14 | CSF1R | 2.17790230 |
| 15 | ERN1 | 2.15522594 |
| 16 | BTK | 2.09429199 |
| 17 | IKBKE | 2.04050354 |
| 18 | SYK | 1.96772632 |
| 19 | RIPK4 | 1.96393273 |
| 20 | ITK | 1.95666754 |
| 21 | TEC | 1.84177794 |
| 22 | JAK1 | 1.81378950 |
| 23 | GRK6 | 1.70106418 |
| 24 | CSK | 1.61004455 |
| 25 | IKBKB | 1.59715732 |
| 26 | HCK | 1.59484416 |
| 27 | LCK | 1.57893576 |
| 28 | IRAK3 | 1.52185789 |
| 29 | FES | 1.47816149 |
| 30 | EEF2K | 1.43813537 |
| 31 | CLK1 | 1.42431905 |
| 32 | TAOK3 | 1.35537722 |
| 33 | MAP2K3 | 1.33602742 |
| 34 | TAOK1 | 1.30670527 |
| 35 | PKN2 | 1.30235112 |
| 36 | LYN | 1.28013923 |
| 37 | BMPR2 | 1.25726246 |
| 38 | EPHB1 | 1.25011668 |
| 39 | MAP3K13 | 1.19541515 |
| 40 | FGFR4 | 1.18922628 |
| 41 | NME2 | 1.17599623 |
| 42 | TAOK2 | 1.17196979 |
| 43 | LRRK2 | 1.14012361 |
| 44 | RPS6KA4 | 1.13275417 |
| 45 | PIM1 | 1.11311325 |
| 46 | MAP3K1 | 1.08985791 |
| 47 | MAP3K10 | 1.08326811 |
| 48 | TRIB3 | 1.06860229 |
| 49 | FLT3 | 1.06621708 |
| 50 | FGFR3 | 0.98776685 |
| 51 | JAK2 | 0.93991129 |
| 52 | MARK3 | 0.91903579 |
| 53 | SIK2 | 0.90670468 |
| 54 | CHUK | 0.90257508 |
| 55 | NLK | 0.89664411 |
| 56 | PIM2 | 0.88506695 |
| 57 | CDC42BPA | 0.81012884 |
| 58 | NEK9 | 0.78726365 |
| 59 | MATK | 0.77507514 |
| 60 | KDR | 0.75926418 |
| 61 | IRAK1 | 0.75595141 |
| 62 | IRAK2 | 0.69645912 |
| 63 | CAMKK2 | 0.68914340 |
| 64 | TESK2 | 0.67961560 |
| 65 | KSR2 | 0.66503870 |
| 66 | PDPK1 | 0.65759239 |
| 67 | PRKCH | 0.64220340 |
| 68 | MARK2 | 0.64202185 |
| 69 | PRKCQ | 0.63806467 |
| 70 | CDK19 | 0.63301927 |
| 71 | GRK7 | 0.62535737 |
| 72 | YES1 | 0.62141484 |
| 73 | CAMK1D | 0.60531330 |
| 74 | SMG1 | 0.58695218 |
| 75 | SIK3 | 0.58512516 |
| 76 | CDK4 | 0.58422612 |
| 77 | MAP3K11 | 0.57930847 |
| 78 | RPS6KA6 | 0.55851819 |
| 79 | PRKD2 | 0.55662133 |
| 80 | STK4 | 0.55390299 |
| 81 | MST4 | 0.55302409 |
| 82 | PAK4 | 0.55281680 |
| 83 | CDK12 | 0.54148006 |
| 84 | TRPM7 | 0.53785374 |
| 85 | TNK2 | 0.52188198 |
| 86 | CDK6 | 0.51847804 |
| 87 | CAMKK1 | 0.51551641 |
| 88 | TGFBR1 | 0.51489960 |
| 89 | MAP3K5 | 0.49987960 |
| 90 | PIK3CG | 0.49877590 |
| 91 | SCYL2 | 0.49707988 |
| 92 | FGR | 0.48457190 |
| 93 | MAPKAPK2 | 0.46648200 |
| 94 | PRKCD | 0.46342567 |
| 95 | PDK1 | 0.46065783 |
| 96 | PTK6 | 0.45429955 |
| 97 | MOS | 0.45399741 |
| 98 | MAP3K12 | 0.44736890 |
| 99 | RPS6KL1 | 0.43860291 |
| 100 | RPS6KC1 | 0.43860291 |
| 101 | MAPK4 | 0.39513532 |
| 102 | EGFR | 0.39144328 |
| 103 | EPHA3 | 0.37913938 |
| 104 | ABL1 | 0.37852371 |
| 105 | MAP2K6 | 0.36128587 |
| 106 | MAP3K8 | 0.36046067 |
| 107 | SIK1 | 0.34272113 |
| 108 | MAP3K7 | 0.33873686 |
| 109 | ADRBK2 | 0.33603313 |
| 110 | NEK2 | 0.33524979 |
| 111 | IGF1R | 0.33086845 |
| 112 | FYN | 0.32720420 |
| 113 | HIPK2 | 0.31958369 |
| 114 | TTN | 0.31553664 |
| 115 | CDK9 | 0.30222230 |
| 116 | MAP3K3 | 0.29075428 |
| 117 | MAPK12 | 0.27907149 |
| 118 | DAPK2 | 0.27213417 |
| 119 | DYRK1B | 0.26175377 |
| 120 | MAP3K6 | 0.25857193 |
| 121 | BMX | 0.25599622 |
| 122 | MAPK11 | 0.25060094 |
| 123 | MAPK7 | 0.24473036 |
| 124 | CAMK1G | 0.23560529 |
| 125 | ALK | 0.23493298 |
| 126 | MAP2K2 | 0.23057514 |
| 127 | MAPK3 | 0.22967259 |
| 128 | SGK3 | 0.21928379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.42004664 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.05595714 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.04876026 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.48869870 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.45978884 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.41043848 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.37341091 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.37327163 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.35949729 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.35576656 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.27092524 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.25312723 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.15667524 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.05909613 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.00803874 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 1.98872112 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.98106128 |
| 18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.84180443 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.83236625 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.81265986 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.78834692 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.75729835 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.69967376 |
| 24 | * Lysosome_Homo sapiens_hsa04142 | 1.66109474 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.64604429 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.59734771 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.58489727 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.56585313 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.54227923 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53393234 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.49692578 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.45864865 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.45564828 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.42341007 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.42079334 |
| 36 | Asthma_Homo sapiens_hsa05310 | 1.36023976 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.29155372 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.27855462 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.27645926 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26954347 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.25074814 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.23479033 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.22037924 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.18729865 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17964255 |
| 46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.10178972 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 1.06682611 |
| 48 | DNA replication_Homo sapiens_hsa03030 | 0.98938908 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.97985770 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96649166 |
| 51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.95911660 |
| 52 | Phagosome_Homo sapiens_hsa04145 | 0.94426437 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91654087 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89704047 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.83673297 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83092365 |
| 57 | Base excision repair_Homo sapiens_hsa03410 | 0.80956468 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.77624020 |
| 59 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.77188119 |
| 60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.74192475 |
| 61 | HTLV-I infection_Homo sapiens_hsa05166 | 0.69963866 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69573461 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67225213 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.64839703 |
| 65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62819362 |
| 66 | Mismatch repair_Homo sapiens_hsa03430 | 0.60862396 |
| 67 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.59953308 |
| 68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59088526 |
| 69 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58906158 |
| 70 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.55520522 |
| 71 | Colorectal cancer_Homo sapiens_hsa05210 | 0.54203742 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54138778 |
| 73 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.52858468 |
| 74 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51656359 |
| 75 | Endocytosis_Homo sapiens_hsa04144 | 0.49988221 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49269083 |
| 77 | Ribosome_Homo sapiens_hsa03010 | 0.49186860 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47887723 |
| 79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46813595 |
| 80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.46544013 |
| 81 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.46079744 |
| 82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.43341517 |
| 83 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.43109393 |
| 84 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42562789 |
| 85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42470801 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | 0.41997995 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41806664 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40657374 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.39679985 |
| 90 | Prion diseases_Homo sapiens_hsa05020 | 0.36015331 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35243698 |
| 92 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35120856 |
| 93 | Homologous recombination_Homo sapiens_hsa03440 | 0.31753145 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.31030111 |
| 95 | Bladder cancer_Homo sapiens_hsa05219 | 0.30924199 |
| 96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27225976 |
| 97 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.26985573 |
| 98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.25595868 |
| 99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.25366482 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24672092 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.24306550 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.23875499 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22478886 |
| 104 | Spliceosome_Homo sapiens_hsa03040 | 0.21714606 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21460043 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.20853946 |
| 107 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.19507634 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.19479575 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.19009350 |
| 110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.18930830 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.18301666 |
| 112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18278540 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.17086492 |
| 114 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.16889251 |
| 115 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.16876712 |
| 116 | Pathways in cancer_Homo sapiens_hsa05200 | 0.15580756 |

